<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Glibenclamide Bp</title>
        <description>Antibacterial/UTI Infection
Nalidixic Acid IP/BP/EP/USP (DMF Available in CTD Format, CEP Submitted)
Anti Diabetic
Glibenclamide IP/BP/EP (DMF Available in CTD Format, CEP Submitted)&lt;br /&gt;
Glyburide USP (USDMF Under Preparation)

</description>
        <link>http://www.elixirpharma.in/product.html</link>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>
        <lastBuildDate>Thu, 27 Jun 2013 14:21:51 +0530</lastBuildDate>
        <pubDate>Thu, 27 Jun 2013 14:21:30 +0530</pubDate>
        <generator>FeedForAll v2.0 (2.0.3.1) unlicensed version http://www.feedforall.com</generator>
        <item>
            <title>Glibenclamide Ip</title>
            <description>Antibacterial/UTI Infection
Nalidixic Acid IP/BP/EP/USP (DMF Available in CTD Format, CEP Submitted)
Anti Diabetic
Glibenclamide IP/BP/EP (DMF Available in CTD Format, CEP Submitted)
Glyburide USP (USDMF Under Preparation)

</description>
            <link>http://www.elixirpharma.in/product.html</link>
            <guid isPermaLink="false">C0687486-D58B-49D3-982D-CEBAEF58700E</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:30 +0530</pubDate>
        </item>
        <item>
            <title>Glibenclamide Ep</title>
            <description>Custom Synthesis of Intermediates, APIs &amp; NCEs
cGMP/Basic GMP Manufacturing of Intermedi ates, APIs &amp; Release
Process Development, Synthetic Route Selec tion &amp; Optimization
Process scale-up and validation
Technology Adaptation &amp; Cost Reduction
Analytical Method Development &amp; Valtion
Stability Studies as per ICH
Regulatory Support for CMC/DMF
</description>
            <link>http://www.elixirpharma.in/chemistry-service.html</link>
            <guid isPermaLink="false">C34084F3-5605-4176-9620-3FB92EE644BA</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:31 +0530</pubDate>
        </item>
        <item>
            <title>Glyburide</title>
            <description>Antibacterial/UTI Infection
Nalidixic Acid IP/BP/EP/USP (DMF Available in CTD Format, CEP Submitted)
Anti Diabetic
Glibenclamide IP/BP/EP (DMF Available in CTD Format, CEP Submitted)
Glyburide USP (USDMF Under Preparation)

</description>
            <link>http://www.elixirpharma.in/product.html</link>
            <guid isPermaLink="false">0EC010DD-545A-42B5-83C5-55B5826E8605</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:32 +0530</pubDate>
        </item>
        <item>
            <title>Nalidixic Acid Bp</title>
            <description>Antibacterial/UTI Infection
Nalidixic Acid IP/BP/EP/USP (DMF Available in CTD Format, CEP Submitted)
Anti Diabetic
Glibenclamide IP/BP/EP (DMF Available in CTD Format, CEP Submitted)
Glyburide USP (USDMF Under Preparation)

</description>
            <link>http://www.elixirpharma.in/product.html</link>
            <guid isPermaLink="false">8E2D45A7-ADCE-4379-B6D8-7C44BB95A41F</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:33 +0530</pubDate>
        </item>
        <item>
            <title>Nalidixic Acid Usp</title>
            <description>Custom Synthesis of Intermediates, APIs &amp; NCEs
cGMP/Basic GMP Manufacturing of Intermedi ates, APIs &amp; Release
Process Development, Synthetic Route Selec tion &amp; Optimization
Process scale-up and validation
Technology Adaptation &amp; Cost Reduction
Analytical Method Development &amp; Valtion
Stability Studies as per ICH
Regulatory Support for CMC/DMF
</description>
            <link>http://www.elixirpharma.in/chemistry-service.html</link>
            <guid isPermaLink="false">C2A26996-EB0A-411B-ACAA-5E12789FA249</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:34 +0530</pubDate>
        </item>
        <item>
            <title>Nalidixic Acid Ip</title>
            <description>Antibacterial/UTI Infection
Nalidixic Acid IP/BP/EP/USP (DMF Available in CTD Format, CEP Submitted)
Anti Diabetic
Glibenclamide IP/BP/EP (DMF Available in CTD Format, CEP Submitted)
Glyburide USP (USDMF Under Preparation)</description>
            <link>http://www.elixirpharma.in/product.html</link>
            <guid isPermaLink="false">9367240B-CD0F-41F6-BCCD-03AE73BD0D43</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:35 +0530</pubDate>
        </item>
        <item>
            <title>Nalidixic Acid Ep</title>
            <description>Antibacterial/UTI Infection
Nalidixic Acid IP/BP/EP/USP (DMF Available in CTD Format, CEP Submitted)
Anti Diabetic
Glibenclamide IP/BP/EP (DMF Available in CTD Format, CEP Submitted)
Glyburide USP (USDMF Under Preparation)</description>
            <link>http://www.elixirpharma.in/product.html</link>
            <guid isPermaLink="false">B4A33942-6ED7-4CE7-819A-68A8E7D8EF21</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:36 +0530</pubDate>
        </item>
        <item>
            <title>Pregabalin</title>
            <description>Elixir Pharma is founded in Sep 2009 by a group of seasoned, experienced techno commercial professionals in Ahmadabad, Gujarat (India). </description>
            <link>http://www.elixirpharma.in</link>
            <guid isPermaLink="false">6E08683A-9711-4F66-A84C-3A73E30B40D4</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:37 +0530</pubDate>
        </item>
        <item>
            <title>Glibenclamide Bp Gujarat</title>
            <description>Elixir Pharma is founded in Sep 2009 by a group of seasoned, experienced techno commercial professionals in Ahmadabad, Gujarat (India). Elixir Pharma aspires to emerge as a leading Fine Chemicals, Intermediates, APIs &amp; Chemistry Services provider to Global Life Science Companies.</description>
            <link>http://www.elixirpharma.in/about.html</link>
            <guid isPermaLink="false">AB25C754-2BE3-4CAE-AD0D-8A7F60542483</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:38 +0530</pubDate>
        </item>
        <item>
            <title>Glibenclamide Ip Gujarat</title>
            <description>Elixir Pharma is founded in Sep 2009 by a group of seasoned, experienced techno commercial professionals in Ahmadabad, Gujarat (India). Elixir Pharma aspires to emerge as a leading Fine Chemicals, Intermediates, APIs &amp; Chemistry Services provider to Global Life Science Companies.</description>
            <link>http://www.elixirpharma.in/about.html</link>
            <guid isPermaLink="false">1C36D40A-4C14-4B63-8ABF-55169880B7A2</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:39 +0530</pubDate>
        </item>
        <item>
            <title>Api manufacturers</title>
            <description>Antibacterial/UTI Infection
Nalidixic Acid IP/BP/EP/USP (DMF Available in CTD Format, CEP Submitted)
Anti Diabetic
Glibenclamide IP/BP/EP (DMF Available in CTD Format, CEP Submitted)
Glyburide USP (USDMF Under Preparation)
</description>
            <link>http://www.elixirpharma.in/product.html</link>
            <guid isPermaLink="false">22564BC6-E836-48CE-8AE1-C1DA08FBE697</guid>
            <pubDate>Thu, 27 Jun 2013 14:21:40 +0530</pubDate>
        </item>
    </channel>
</rss>
